Nobody could have predicted this… and by “nobody“, we mean everybody of course.
As the political media and democrats simultaneously drop their COVID-19 social distancing concerns to celebrate Joe Biden in the streets and DNC venues, as anticipated an effective vaccine is announced. Within the announcement Pfizer admits they stalled announcing the results of the study in October, preferring to wait until after the election.
Not only was COVID fear hyped and weaponized for maximum political narrative engineering value, but news of the COVID vaccine was withheld for the same intents.
STATNEWS […] Gruber said that Pfizer and BioNTech had decided in late October that they wanted to drop the 32-case interim analysis. At that time, the companies decided to stop having their lab confirm cases of Covid-19 in the study, instead leaving samples in storage. The FDA was aware of this decision.
Discussions between the agency and the companies concluded, and testing began this past Wednesday. When the samples were tested, there were 94 cases of Covid in the trial. The DSMB met on Sunday.
This means that the statistical strength of the result is likely far stronger than was initially expected. It also means that if Pfizer had held to the original plan, the data would likely have been available in October, as its CEO, Albert Bourla, had initially predicted. (read more)